Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × larotrectinib × Clear all

Sponsor

Conditions

Central Nervous System Neoplasms 3 Wilms Tumor 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Sarcoma, Ewing 1 Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion 1 Histiocytic Sarcoma 1

Interventions

Prednisone 110 Docetaxel 86 Leuprolide 79 enzalutamide 67 Abiraterone Acetate 67 bicalutamide 53 Goserelin 50 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42 Radiotherapy 39 abiraterone 24 gallium 68 PSMA-11 23 Magnetic Resonance Spectroscopy 23 apalutamide 22 Gonadotropin-Releasing Hormone 22 luprolide acetate gel depot 21 sipuleucel-T 20 Androgen Antagonists 20 Triptorelin Pamoate 18 Radiosurgery 18 cabazitaxel 16 Flutamide 16 pembrolizumab 15 Radiotherapy, Intensity-Modulated 15 cabozantinib 14 Prednisolone 14 Dutasteride 14 Dexamethasone 14 radium Ra 223 dichloride 13 fluciclovine F-18 12 Radiation 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡